
Jonathan Schott
@jmschott
Prof @drcionucl • Neurologist @uclh • @MRC Investigator • @nihr Senior Investigator • CMO @alzresearchuk • Dementia, ageing, biomarkers
ID: 56383736
13-07-2009 14:20:51
2,2K Tweet
3,3K Followers
500 Following

Congratulations to Will Coath on passing his PhD viva exploring amyloid and tau PET in the Insight 1946 birth cohort! Many thanks to examiners Prof Alexander Hammers and Paresh Malhotra and fellow supervisors Michael Schöll and Jonathan Schott


How and when to use blood tests for dementia: TL, DR — outside of research not (yet) in people who don’t have symptoms. Pleased to contribute to this piece in the The Observer theguardian.com/science/2025/f…


Such a shame not being able to be at #ARUKconf25 in person, but tuning in from the US - wonderful discussion on fluid markers in dementia, and undergoing UK efforts! Thanks Alzheimer's Research UK for bringing the community together on this key topic and funding great work in this area!


10th annual UCL Queen Square Institute of Neurology neurology course is this June. Book your place now. ucl.ac.uk/ion/neurology-…


The Alzheimer's Association Global Biomarker Standardization Consortium evaluated p-tau assays to determine which assay has the greatest fold change between AD and non-AD. Explore findings recently published in Alzheimer's & Dementia alz-journals.onlinelibrary.wiley.com/doi/full/10.10… #AlzResearch

am honoured to be appointed an National Institute for Health and Care Research Senior investigator. I look forward to helping provide research leadership to the NIHR Faculty, and promoting the next generation of researchers working to improve outcomes for patients UCLH UK Dementia Research Institute Alzheimer's Research UK NIHR UCLH Biomedical Research Centre

Congratulations to the BRC-supported researchers who have been appointed or re-appointed as National Institute for Health and Care Research Senior Investigators in the 2025 round of awards, Prof Jonathan Schott, Prof Sonia Johnson, Prof Henry Houlden & Prof Rob Heyderman 🔗uclhospitals.brc.nihr.ac.uk/news/brc-resea…


“There’s great progress being made in biomarker technology…We need to push ahead” — Jonathan Schott on the state of biomarker tools.




Just out in Arquivos de Neuro-Psiquiatria. Pros and cons of antiamyloid therapies for Alzheimer's disease. Opinion papers by Professors Jonathan Schott, Charles Marshall, Ricardo Nitrini and Adalberto Studart Neto.

🌞 How can you take care of your brain health in the summer months? Ahead of #DementiaActionWeek, Prof Jonathan Schott (UCL Queen Square Institute of Neurology) shares his top tips. buff.ly/vMs2Agu

Honoured to be elected Academy of Medical Sciences FMedSci and to be in such distinguished company ucl.ac.uk/news/2025/may/… UCL Alzheimer's Research UK Alzheimer's Association UK Dementia Research Institute


My son Otto is doing the London-Brighton cycle to raise funds for Research at ARUK Alzheimer's Research UK next weekend — please support if you can! #JustGiving justgiving.com/page/team-otto…


I’m honoured to be joining the DRI as a group leader — and look forward to helping translate the amazing science being done there into benefits for people with, and at risk of, dementia. Research at ARUK National Institute for Health and Care Research Academy of Medical Sciences UCL Brain Sciences

We’re proud to see our Chief Medical Officer, Jonathan Schott named a Group Leader at the UK DRI at UCL!


Are you a UK health professional working in dementia? If so, please take this *5 min* survey to help Alzheimer's Research UK better understand the views of HCPs working across the NHS. Thank you! forms.office.com/Pages/Response…